‘An important milestone:’ Canada approves expensive new drug that can slow Alzheimer’s disease CTV NewsHealth Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease GlobeNewswireHealth Canada authorizes long-awaited drug to slow early-stage Alzheimer’s disease CityNews TorontoHealth Canada approves drug that slows progression of Alzheimer’s disease The Globe and MailHealth Canada Grants Authorization for LEQEMBI® (lecanemab) for the Treatment of Early Alzheimer’s Disease Newswire Canada
